AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the pricing of its initial public offering of
AUSTIN, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- MicroTransponder, Inc., a commercial-stage medical device company today announced that it has changed its corporate name to Mobia Medical, Inc. (“Mobia”), effective immediately. The Company develops and markets the breakthrough Vivistim ® Paired VNS™
American Heart Association consortium advances development of evidence-based health tech solutions AUSTIN, Texas, Jan. 16, 2026 (GLOBE NEWSWIRE) -- MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® Paired VNS™ System for chronic
